Allspring Global Investments
IGMS

Allspring Global Investments’s IGM Biosciences IGMS Stock Holding History

Allspring Global Investments’s Portfolio IGMS Stock Details IGMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-2,670
Closed -$45.4K – 2845
2022
Q4 		$45.4K Sell
2,670
-59
-2% -$1.18K ﹤0.01% 2361
2022
Q3 		$62K Buy
+2,729
New +$55.1K ﹤0.01% 2262

Other funds holding IGMS

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Allspring Global Investments's IGMS Position: Q1 2023 in Review

Allspring Global Investments sold out of IGM Biosciences (IGMS) in Q1 2023, closing a stake of 2,670 shares — an estimated $45.4K sold.

Allspring Global Investments first reported a position in IGMS in Q3 2022 and held it in 2 quarters. The position peaked at $62K in Q3 2022. 74 funds tracked by Wall St. Rank hold IGMS as of Q1 2023.

  • Allspring Global Investments reported no remaining IGM Biosciences position as of Q1 2023 after selling out during the quarter.
  • Allspring Global Investments sold 2,670 IGM Biosciences shares in Q1 2023, an estimated $45.4K.
  • Allspring Global Investments first reported a position in IGM Biosciences in Q3 2022 and held it in 2 quarters.
  • Allspring Global Investments's IGM Biosciences position peaked at $62K in Q3 2022.
  • 74 funds tracked by Wall St. Rank held IGM Biosciences as of Q1 2023.

Based on Allspring Global Investments's 13F filing for Q1 2023, filed 13 Apr 2023.